Revenues

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenues

Revenues

As discussed in Note 1, Organization and Business, we deconsolidated UpHealth Holdings and its subsidiaries as of September 30, 2023; accordingly, the financial position of UpHealth Holdings as of December 31, 2022 and financial results of UpHealth Holdings and its subsidiaries for the year ended December 31, 2022 and for the nine months ended September 30, 2023 are included in our consolidated financial statements and the financial position of UpHealth Holdings as of December 31, 2023 and the financial results of UpHealth Holdings and its subsidiaries for the three months ended December 31, 2023 are not included in our consolidated financial statements. The filing of a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code, as discussed in Note 1, Organization and Business, occurred on September 19, 2023. Management concluded that it would use the September 30, 2023 date for deconsolidation, as the last 12 days in the month were determined to not be material.

As discussed in Note 1, Organization and Business, we deconsolidated Glocal during the three months ended September 30, 2022; therefore, the financial results of Glocal in the six months ended June 30, 2022 are included in our consolidated financial statements, and the financial position of Glocal as of December 31, 2023 and 2022 and the financial results of Glocal in the six months ended December 31, 2022 and the year ended December 31, 2023 are not included in our consolidated financial statements.

Revenues by service offering consisted of the following: 

	For the year ended December 31,
(In thousands)	2023		2022
Services	$	110,039	$	110,953
Licenses and subscriptions	6,548		12,566
Products	13,411		35,284
Total revenues	$	129,998	$	158,803

Revenues by geography consisted of the following:

	For the year ended December 31,
(In thousands)	2023		2022
Americas	$	129,998	$	151,899
Asia	—		6,904
Total revenues	$	129,998	$	158,803

Our revenues are entirely derived from the healthcare industry. Revenue recognized over-time was approximately 87% and 74% of total revenues during the years ended December 31, 2023 and 2022, respectively.

Contract Assets

There were no impairments of contract assets, consisting of unbilled receivables, during fiscal 2023 and 2022, respectively.

The change in contract assets was as follows: 

(In thousands)	December 31, 2023		December 31, 2022
Unbilled receivables, beginning of period	$	694	$	784
Reclassifications to billed receivables	(694)		(784)
Revenues recognized in excess of period billings	603		694
Deconsolidation of subsidiaries	(603)		—
Unbilled receivables, end of period	$	—	$	694

Contract Liabilities

The change in contract liabilities, consisting of deferred revenue, was as follows:

(In thousands)	December 31, 2023		December 31, 2022
Deferred revenue, beginning of period	$	2,738	$	2,649
Revenues recognized from balances held at the beginning of the period	(2,738)		(2,027)
Revenues deferred from period collections on unfulfilled performance obligations	3,694		2,980
Deconsolidation of subsidiary	(3,646)		(622)
Reclassified to liabilities held for sale (See Note 4)	—		(242)
Deferred revenue, end of period	$	48	$	2,738

Revenue recognized ratably over time is generally billed in advance and includes SaaS internet hosting, subscriptions, construction of digital dispensaries, and related consulting, implementation, services support, and advisory services.

Revenue recognized as delivered over time includes professional services billed on a time and materials basis, and fixed fee professional services and training classes that are primarily billed, delivered, and recognized within the same reporting period.

Approximately 2.1% of revenue recognized during the year ended December 31, 2023 was from the deferred revenue balance existing as of December 31, 2022. Approximately 1.3% of the revenue recognized during the year ended December 31, 2022 was from the deferred revenue balance existing as of